Palisade Bio (PALI) Net Margin Growth (3y) (2014 - 2023)

Palisade Bio (PALI) Net Margin Growth (3y) (2014 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Palisade Bio 985.76 -132.63 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 3.92 Mn
Dec 31, 2020 -12.93 Mn
Sep 30, 2020 2.89 Mn
Jun 30, 2020 10.37 Mn
Mar 31, 2020 13.64 Mn
Dec 31, 2019 -2.01 Mn
Sep 30, 2019 11.89 Mn
Jun 30, 2019 14.13 Mn
Mar 31, 2019 16.52 Mn
Dec 31, 2018 11.93 Mn
Sep 30, 2018 14.29 Mn
Jun 30, 2018 21.71 Mn
Mar 31, 2018 7.62 Mn
Dec 31, 2017 11.71 Mn
Sep 30, 2017 -1.37 Mn
Jun 30, 2017 -4.47 Mn
Mar 31, 2017 -3.44 Mn
Dec 31, 2016 6.72 Mn
Sep 30, 2016 6.16 Mn
Jun 30, 2016 8.43 Mn